Key facts
- This page summarizes Charles J. Homcy's Form 4 filing for Maze Therapeutics, Inc. (MAZE).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 May 2026, 16:13.
Charles J. Homcy - 04 May 2026 Form 4 Insider Report for Maze Therapeutics, Inc. (MAZE)
- Reporting relationship
- Director
- Issuer ticker
- MAZE
- Reported as of
- 04 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 May 2026, 16:13:06 UTC
- Prior SEC filing
- 21 Nov 2025
- Next SEC filing
- 10 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Courtney Phillips, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Charles J. Homcy filed Form 4 for Maze Therapeutics, Inc. (MAZE) on 06 May 2026.
Change
- Previous filing in this sequence was filed on 21 Nov 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001192591
Primary reporting owner
HOMCY CHARLES J
- Relationship
- Director
- Address
- C/O MAZE THERAPEUTICS, INC., 171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
- Signature
- /s/ Courtney Phillips, as attorney-in-fact
- Signature date
- 06 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MAZE
transaction
Common Stock
Gift
- Transaction value
- Shares
- -7,422
- Change %
- -19%
- Price
- $0.000000*
- Shares after
- 31,113
- Date
- 04 May 2026
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The reported transaction represents a gift, for no consideration, which is exempt pursuant to Rule 16b-5.
Footnote F2
The total reflected in Column 5 of Table I includes shares which were previously held directly by the Charles J. Homcy Revocable Trust UA 11/4/1998.